Image

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Research Study on CEA CAR-T Cells for Advanced Malignant Solid Tumors

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates CEA positive advanced malignant solid tumors. It focuses on understanding how the investigational medication interacts with the body and its safety in people with this condition.

Researchers will evaluate the safety and tolerability of the investigational medication. They will also study how the body processes the medication.

  • Who can participate: Adults aged 18 and older with CEA positive advanced malignant solid tumors, including those who have progressed after standard treatments and have specific tumor types like colorectal or gastric cancer.
  • Study details: Participants will receive an investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
Print
Study details
    Colorectal Cancer
    Esophagus Cancer
    Gastric Cancer
    Pancreas Cancer
    Non-small Cell Lung Cancer
    Breast Cancer
    Bile Duct Cancer

NCT06043466

Chongqing Precision Biotech Co., Ltd

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.